Barbara Friedland

Barbara Friedland is an associate in the Population Council’s HIV and AIDS program. Friedland has been involved in both clinical and behavioral research, primarily focused on HIV prevention. She has also coordinated several international clinical trials of the Council’s first candidate microbicide, Carraguard®, and is currently managing the first in-human study of the Council’s ARV-based microbicide, PC-1005 (MIV-150 and zinc acetate in a carrageenan gel).


FROM THE PIPELINE | Fast track to an MPT: Development of a dual-purpose pill containing oral PrEP and an oral contraceptive

Monday, 22 July 2019 Written by // Barbara Friedland Series // From the Pipeline Tags // contraceptive, dual-purpose, pill, Population Council, prevention, women

Imagine if women could take one pill every day and be protected from unintended pregnancy AND HIV? 

And what if this pill was available within several years? 

We believe the fastest route to a contraceptive MPT is to combine two products that are ALREADY ON THE MARKET into a single pill.

A dual-purpose pill has the potential to play an important role in helping women protect themselves against both unintended pregnancy and HIV infection.

The Population Council is working with partners to fast-track development of dual- purpose pill

Recent Posts

Any thoughts? Contact us to learn more about the submission process.


Spread the word about the promise of MPTs.


We will go further together – join the movement for MPTs.


Your financial and in-kind support can help make MPTs a reality.